92 related articles for article (PubMed ID: 15599322)
1. Transfer of human leukocytes into double-knockout Pfp-/-Rag2-/- mice grafted with human skin: increased accumulation of neutrophils in human dermal microvessels.
Ullrich S; Schumacher U; Ai M; Tiemann B; Gay S; Schechner JS; Pober JS; Gross WL; Csernok E
Transplantation; 2004 Nov; 78(10):1557-9. PubMed ID: 15599322
[TBL] [Abstract][Full Text] [Related]
2. Perforin-dependent direct cytotoxicity in natural killer cells induces considerable knockdown of spontaneous lung metastases and computer modelling-proven tumor cell dormancy in a HT29 human colon cancer xenograft mouse model.
Brodbeck T; Nehmann N; Bethge A; Wedemann G; Schumacher U
Mol Cancer; 2014 Nov; 13():244. PubMed ID: 25373310
[TBL] [Abstract][Full Text] [Related]
3. Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse.
Murray AG; Petzelbauer P; Hughes CC; Costa J; Askenase P; Pober JS
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9146-50. PubMed ID: 8090783
[TBL] [Abstract][Full Text] [Related]
4. Human CD4+ T cells mediate rejection of porcine xenografts.
Friedman T; Shimizu A; Smith RN; Colvin RB; Seebach JD; Sachs DH; Iacomini J
J Immunol; 1999 May; 162(9):5256-62. PubMed ID: 10228000
[TBL] [Abstract][Full Text] [Related]
5. Increased numbers of spontaneous SCLC metastasis in absence of NK cells after subcutaneous inoculation of different SCLC cell lines into pfp/rag2 double knock out mice.
Sodeur S; Ullrich S; Gustke H; Zangemeister-Wittke U; Schumacher U
Cancer Lett; 2009 Sep; 282(2):146-51. PubMed ID: 19349111
[TBL] [Abstract][Full Text] [Related]
6. NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment.
Shultz LD; Banuelos S; Lyons B; Samuels R; Burzenski L; Gott B; Lang P; Leif J; Appel M; Rossini A; Greiner DL
Transplantation; 2003 Oct; 76(7):1036-42. PubMed ID: 14557749
[TBL] [Abstract][Full Text] [Related]
7. Chronic human skin graft rejection in severe combined immunodeficient mice engrafted with human PBL from an HLA-presensitized donor.
Kawamura T; Niguma T; Fechner JH; Wolber R; Beeskau MA; Hullett DA; Sollinger HW; Burlingham WJ
Transplantation; 1992 Mar; 53(3):659-65. PubMed ID: 1549862
[TBL] [Abstract][Full Text] [Related]
8. Human TNF can induce nonspecific inflammatory and human immune-mediated microvascular injury of pig skin xenografts in immunodeficient mouse hosts.
Kirkiles-Smith NC; Tereb DA; Kim RW; McNiff JM; Schechner JS; Lorber MI; Pober JS; Tellides G
J Immunol; 2000 Jun; 164(12):6601-9. PubMed ID: 10843720
[TBL] [Abstract][Full Text] [Related]
9. Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice.
Nomi H; Tashiro-Yamaji J; Yamamoto Y; Miura-Takeda S; Miyoshi-Higashino M; Takahashi T; Azuma H; Ueda H; Katsuoka Y; Kubota T; Yoshida R
J Immunol; 2007 Aug; 179(4):2180-6. PubMed ID: 17675477
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease.
Braun MY; Lowin B; French L; Acha-Orbea H; Tschopp J
J Exp Med; 1996 Feb; 183(2):657-61. PubMed ID: 8627178
[TBL] [Abstract][Full Text] [Related]
11. NK cells promote peritoneal xenograft rejection through an IFN-gamma-dependent mechanism.
Lin ML; Zhan Y; Nutt SL; Brady J; Wojtasiak M; Brooks AG; Lew AM
Xenotransplantation; 2006 Nov; 13(6):536-46. PubMed ID: 17059581
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte recruitment into human skin transplanted onto severe combined immunodeficient mice induced by TNF-alpha is dependent on E-selectin.
Yan HC; Delisser HM; Pilewski JM; Barone KM; Szklut PJ; Chang XJ; Ahern TJ; Langer-Safer P; Albelda SM
J Immunol; 1994 Mar; 152(6):3053-63. PubMed ID: 7511636
[TBL] [Abstract][Full Text] [Related]
14. TNF contributes to the immunopathology of perforin/Fas ligand double deficiency.
Cretney E; Street SE; Smyth MJ
Immunol Cell Biol; 2002 Oct; 80(5):436-40. PubMed ID: 12225379
[TBL] [Abstract][Full Text] [Related]
15. Perforin-independent rejection of transplanted human stem cells.
Kaiser S; Kägi D; Ihorst G; Kapp U
Clin Exp Immunol; 2006 Aug; 145(2):332-8. PubMed ID: 16879254
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen-DR matching improved skin graft survival from transgenic pigs to accommodate SCID mice reconstituted with human peripheral blood mononuclear cells.
Tu CF; Tai HC; Chen CM; Huang TT; Lee JM; Yang TS; Chen CH; Tseng YL; Chou NK; Lee PH
Transplant Proc; 2008 Mar; 40(2):578-80. PubMed ID: 18374133
[TBL] [Abstract][Full Text] [Related]
17. High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.
Nanni P; Nicoletti G; Landuzzi L; Croci S; Murgo A; Palladini A; Antognoli A; Ianzano ML; Stivani V; Grosso V; Maira SM; García-Echeverría C; Scotlandi K; De Giovanni C; Lollini PL
Eur J Cancer; 2010 Feb; 46(3):659-68. PubMed ID: 20031388
[TBL] [Abstract][Full Text] [Related]
18. Survival of islet grafts in perforin-deficient mice.
Lu X; Ledermann B; Borel JF
Transplant Proc; 1995 Dec; 27(6):3262-3. PubMed ID: 8539943
[No Abstract] [Full Text] [Related]
19. TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-gamma double knockout effector T cells.
Poehlein CH; Hu HM; Yamada J; Assmann I; Alvord WG; Urba WJ; Fox BA
J Immunol; 2003 Feb; 170(4):2004-13. PubMed ID: 12574370
[TBL] [Abstract][Full Text] [Related]
20. CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice.
Behrens CK; Igney FH; Arnold B; Möller P; Krammer PH
J Immunol; 2001 Mar; 166(5):3240-7. PubMed ID: 11207278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
